Gardasil was fast-tracked
In 2006 when the HPV vaccine Gardasil was licensed and marketed to young girls and women 9-26 years of age, the phase 3 clinical trials had not been completed. This meant that the benefits of the vaccine and any safety issues arising from it were not known. The time period from clinical trial to recommending the vaccine was only 4 years. According to Dr Diane Harper, one of Merck’s HPV […]